Itchy EMA wants to suspend or niche tetrapezam meds
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the suspension of medicines containing the benzodiazepine tetrapezam throughout the European Union.